Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Clinical trial NCT04719273 · COMPLETED

Trial details

NCT number: NCT04719273
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Endometrial Adenocarcinoma Refractory Endometrial Carcinoma Refractory Endometrial Clear Cell Adenocarcinoma Refractory Endometrial Endometrioid Adenocarcinoma Refractory Endometrial Mixed Cell Adenocarcinoma Refractory Endometrial Serous Adenocarcinoma Refractory Endometrial Undifferentiated Carcinoma

Start date: 2021-01-28
Primary completion: 2025-03-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.